Witnessing the stock’s movement on the chart, on November 23, 2020, Novavax Inc. (NASDAQ: NVAX) set off with pace as it heaved 8.58% to $93.98. During the day, the stock rose to $98.45 and sunk to $88.00 before settling in for the price of $86.55 at the close. Taking a more long-term approach, NVAX posted a 52-week range of $3.54-$189.40.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -9.50%. Meanwhile, its Annual Earning per share during the time was 5.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 44.90%. This publicly-traded company’s shares outstanding now amounts to $63.66 million, simultaneously with a float of $62.93 million. The organization now has a market capitalization sitting at $5.97 billion. At the time of writing, stock’s 50-day Moving Average stood at $99.21, while the 200-day Moving Average is $71.03.
If we measure the efficiency of the company that is accounted for 165 employees. It has generated 113,103 per worker during the last fiscal year. Meanwhile, its income per employee was -804,206. The stock had 4.98 Receivables turnover and 0.10 Total Asset turnover. For the Profitability, stocks operating margin was -694.44 and Pretax Margin of -711.04.
Novavax Inc. (NVAX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Novavax Inc.’s current insider ownership accounts for 0.20%, in contrast to 52.20% institutional ownership. According to the most recent insider trade that took place on Nov 16, this organization’s President and CEO sold 52,316 shares at the rate of 90.65, making the entire transaction reach 4,742,667 in total value, affecting insider ownership by 20,495. Preceding that transaction, on Oct 01, Company’s President and CEO sold 2 for 108.57, making the whole transaction’s value amount to 217. This particular insider is now the holder of 20,494 in total.
Novavax Inc. (NVAX) Earnings and Revenue Records
As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$3.21 earnings per share (EPS) for the period falling under the consensus outlook (set at $1.73) by -$4.94. This company achieved a net margin of -711.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.04 per share during the current fiscal year.
Novavax Inc.’s EPS increase for this current 12-month fiscal period is 44.90% and is forecasted to reach 14.40 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by 0.00% through the next 5 years, which can be compared against the 5.60% growth it accomplished over the previous five years trading on the market.
Novavax Inc. (NASDAQ: NVAX) Trading Performance Indicators
Let’s observe the current performance indicators for Novavax Inc. (NVAX). It’s Quick Ratio in the last reported quarter now stands at 2.80. The Stock has managed to achieve an average true range (ATR) of 7.71. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 29.16. Similarly, its price to free cash flow for trailing twelve months is now 120.66.
In the same vein, NVAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.22, a figure that is expected to reach -1.10 in the next quarter, and analysts are predicting that it will be 14.40 at the market close of one year from today.
Technical Analysis of Novavax Inc. (NVAX)
Going through the that latest performance of [Novavax Inc., NVAX]. Its last 5-days volume of 3.56 million was inferior to the volume of 7.52 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 53.87% While, its Average True Range was 7.79.
Raw Stochastic average of Novavax Inc. (NVAX) in the period of the previous 100 days is set at 15.78%, which indicates a major fall in contrast to 70.66% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 97.75% that was higher than 95.67% volatility it exhibited in the past 100-days period.